Arkolith/Insider Trading/ITOS/Form 4

Detheux Michel

Chief Executive OfficeriTeos Therapeutics, Inc. (ITOS) · full profile →Form 4 · filed Jun 11, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.0M
Net Open-Market Flow
-$1.0M
Transactions
16
10 non-derivative · 6 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 10, 2025Option exercise(M)94K$4.30$404K94K
Jun 10, 2025Option exercise(M)18K$4.30$77K154K
Jun 10, 2025Sell(S)44K$10.02$440K0
Jun 10, 2025Option exercise(M)44K$4.30$189K44K
Jun 10, 2025Option exercise(M)8K$4.30$36K144K
Jun 10, 2025Sell(S)8K$10.02$84K136K
Jun 9, 2025Option exercise(M)8K$4.30$36K144K
Jun 9, 2025Sell(S)8K$10.03$84K136K
Jun 9, 2025Option exercise(M)44K$4.30$189K44K
Jun 9, 2025Sell(S)44K$10.03$440K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 10, 2025Option exercise(M)44K—$094K
Jun 10, 2025Option exercise(M)18K—$00
Jun 10, 2025Option exercise(M)94K—$03
Jun 10, 2025Option exercise(M)8K—$018K
Jun 9, 2025Option exercise(M)8K—$026K
Jun 9, 2025Option exercise(M)44K—$0138K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-085047) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML